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ABSTRACT
This thesis explores the role of pharmacists in prenatal health care for women with
chronic diseases. This study consists of a systematic review of Medline and Academic Search
Premier listed articles concerning pregnant women and obesity, hypertension, or diabetes and
pharmacy, focusing special attention on 40 articles. The second part of the study consisted of
pharmacist interviews with thirteen pharmacists on how they view the current role of
pharmacists in caring for pregnant women who are obese, hypertensive, and diabetic. The
literature review suggested that chronic diseases can have a detrimental effect on children,
and that there were many gaps in knowledge on how to treat pregnant women with chronic
diseases. The pharmacist interviews revealed that pharmacists do not currently have an
established role in prenatal care for women with chronic diseases but provide medication
information for these women. In conclusion, chronic diseases during pregnancy are
detrimental to the health of both the mother and the child. Pharmacists can work with other
health professionals to provide education and high quality care to this population.
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INTRODUCTION
This thesis investigates the role of pharmacists in providing prenatal care to women
who are obese, hypertensive, and diabetic. I conducted a systematic review of literature from
Academic Search Premier and Medline to learn about how pregnant women with chronic
noncommunicable diseases are treated. After reviewing the outcomes, I interviewed
pharmacists to investigate their view on how pharmacy can be connected with public health
and nutrition can be used to improve the efficacy of prenatal care.
Mississippi has the highest infant death rate in the United States. According to the
Mississippi State Department of Health, 8.2 infants out of 1,000 live births died within the
first year of life in 2014. Premature birth, which is defined as less than 37 weeks gestation, is
the leading cause of infant mortality in Mississippi, followed by birth defects and sudden
infant death syndrome (Collier, 2015). Women entering pregnancy with conditions like
obesity, hypertension and diabetes have an increased risk for premature birth. According to
the Mississippi Behavioral Risk Factor Surveillance System Annual Prevalence Report
conducted in 2014 by the Mississippi State Department of Health, 37% of women in
Mississippi between ages 18 and 44 were obese, 17% had hypertensive disorders, and 4%
had diabetes (MSDH, 2015). These numbers show that health interventions are necessary to
minimize complications due to chronic diseases.
A common recommendation for pregnant women with chronic diseases is to see a
high risk obstetrician/gynecologist. However, this may not be an option for women with
limited healthcare access. Even women who can visit high risk specialists need extra support.
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Pharmacists are the most accessible healthcare providers, since most women purchase
prenatal vitamins at the pharmacy. Pharmacists do not require appointments for patient
counseling, unlike physicians’ offices. By developing a protocol for pharmacists to provide
care for these patients, we could improve birth outcomes among high risk mothers.
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SYSTEMATIC LITERATURE REVIEW
I searched Academic Search Premier and Medline Plus using combinations of three
keywords to find articles. I conducted this literature review to see the current
recommendations for prenatal pharmaceutical care for women with chronic diseases. I also
researched how maternal chronic disease can affect children. I only reviewed articles that
were complete and peer reviewed. The first set of terms were neonatal, prenatal, and
antenatal. The second terms were maternal health, hypertension, high blood pressure,
diabetes, noncommunicable disease, and obesity. The third terms were pharmacists and
pharmacy. After conducting this search, I thoroughly reviewed 40 articles published between
January 2004 and July 2014.
Most of the articles I found focused on the effects of obesity in pregnancy. Many
articles also focused on gestational diabetes and pregnancy, and fewer articles focused on
hypertension and pregnancy. Few articles looked into practice guidelines for treatment of
patients.
Obesity
The most consistent result I found was that overweight and obese mothers have
longer hospital stays than normal weight mothers (Chu et al., 2008). Longer hospital stays
raise healthcare costs for these women and their families. In situations where the expectant
mother is of limited financial means, these costs are ultimately absorbed by federal, state
and/or local governments, as well as medical providers. Obese women have a higher risk of
3

fetal effects like macrosomia, intrauterine growth restriction, and fetal death in utero
(Radulescu, Munteanu, Popa, & Cirstoiu, 2013). One Romanian study surveyed birth
outcomes for children born to obese mothers at a Bucharest University Emergency Hospital.
The study included all children born from January 1, 2012 to December 31, 2012. The
researchers found that children born to obese mothers had a higher risk of needing intensive
care after birth, higher risk of caesarean surgery, and higher risk of thromboembolic
complications (Radulescu et al., 2013). The researchers also found that complications are
increased in both number and severity with increasing maternal obesity. A retrospective
study of fetal-infant mortality in a Healthy Start community in Michigan showed that obesity,
inadequate weight gain and anemia contribute as much to fetal and infant mortality as
maternal substance abuse (Kothari, Wendt, Liggins, Overton, & del Carmen Sweezy, 2011).
The study also showed that the fetal mortality population was more likely that the infant
mortality population to have no insurance, inadequate prenatal care, and previous fetal death.
These findings show that health professionals should emphasize maternal nutrition and the
importance of prenatal care to patients. Children of obese women are more likely to be born
overweight or be born underweight (Zhang, Rattanatray, McMillen, Suter, & Morrison,
2011). Many studies have shown that children born either underweight or overweight have a
higher risk of adult obesity (McMillen et al., 2008). These complications can lead to an
intergenerational cycle of obesity, which perpetuates poor health outcomes.
Maternal obesity affects fetal growth and programs children’s metabolisms for a
lifetime of obesity. However, the standard advice to lose weight and exercise is not optimal
because studies have shown that losing weight while pregnant can cause more problems than
it solves. Children exposed to fetal undernutrition are at greater risk for coronary heart
4

disease, increased body mass index, and increased glucose sensitivity due to decreased
insulin production (McMillen et al., 2008). Maternal undernutrition can lead to the fetus
receiving less oxygen and glucose than necessary. If an overweight woman tries to lose
weight within three months of conception, the child may be programmed for a lifetime of
adversity, leading to obesity (McMillen et al., 2008). This undernutrition programs children
to have a thrifty phenotype, meaning that their metabolic systems use calories more
efficiently, leading to obesity.
Obese women also have a higher risk of hypertension and gestational diabetes than
non-obese women. Children born to mothers with either gestational diabetes or obesity have
a significantly increased chance of adult obesity and metabolic syndrome (McMillen et al.,
2008). Fetal over nutrition can lead to children developing metabolic disorders later in life.
Researchers have shown a connection between maternal obesity and risk of their children’s
obesity. They have hypothesized that maternal obesity can alter fetal appetite regulating
networks, leading to altered postnatal development and an increased risk of obesity
(Muhlhausler, 2007). Physiological responses to over nutrition can contribute to an
intergenerational cycle of obesity.
Several animal studies have shown a link between maternal obesity and childhood
obesity. Maternal ingestion of carbohydrates have a greater effect on the offspring’s future
health than maternal weight gain during pregnancy (Beck, Richy, Archer, & Mercer, 2012).
Maternal diet affect offspring’s food preferences throughout their lives. In a study on rats, a
maternal junk food diet altered the offspring’s reward systems (Ong & Muhlhausler, 2011).
In this study, the junk food diet had a significantly higher amount of fat and sugar than
standard rat chow. Another study conducted by the same researchers showed that maternal
5

junk food diet had a different effect on male and female offspring. Male rats born to mothers
who were fed junk food were normal weight as adults. However, the female offspring of
mothers fed junk food had a higher average body fat mass (Ong & Muhlhausler, 2014). The
researchers showed how reward pathways in the brain were altered by maternal diet, as rats
who’s mothers were fed junk food showed upregulation of dopamine-regulated genes when
fed junk food as adults. These results indicate that maternal diet could play a role in their
children’s food preferences.
Another study focused on how overnutrition in late pregnancy relates to maternal
obesity as a risk factor for intergenerational obesity (Zhang et al., 2011). In this study,
researchers studied lambs that were exposed to high levels of maternal nutrition in late
pregnancy. The researchers observed that maternal overnutrition in late pregnancy combined
with maternal obesity formed a two-hit risk factor for lamb obesity. The researchers also
showed that lambs born to obese mothers who had a restricted diet in late pregnancy were
less likely to be obese later in life but had a greater stress response (Zhang et al., 2011).
These results show that maternal obesity and nutrition should be closely monitored during
pregnancy to minimize adverse effects to the child. Maternal BMI plays a role in the
offspring’s BMI. Children born to overweight mothers are more likely to be overweight
(Zhang et al., 2011). In swine, a maternal diet high in saturated fat led to offspring with
metabolic and developmental abnormalities (Torres-Rovira et al., 2014). In a study
conducted in lambs, researchers used an embryo transfer model to observe if maternal
obesity and/ or weight loss had an effect on the offspring’s hepatic fatty acid metabolism
(Nicholas et al., 2014). The researchers found that oocytes and developing embryos were
both sensitive to the effects of maternal obesity which can lead to adverse effects for
6

offspring. The embryos exposed to dietary restrictions in obese ewes still showed decreased
function in hepatic enzymes for metabolizing fatty acids. These results suggest that weight
loss during pregnancy does not prevent children from experiencing adverse effects of
maternal obesity. The researchers stated that more studies are needed on the metabolic
benefits and costs on different dietary interventions in groups of women.
Another group of researchers studied the effects of maternal overnutrition on hepatic
enzymes as well (Philp et al., 2008). The researchers determined that maternal overnutrition
can suppress AMP- activated protein kinase in the liver, which can lead to increased glucose
production and basal hyperglycemia in lambs of overfed ewes (Philp et al., 2008). One study
conducted in rats examined the effects of early postnatal malnutrition on breastfeeding pups.
The mothers were fed protein restricted diets while lactating, which caused the pups to
develop hypoinsulinemia and may have adverse effects on the autonomic nervous system that
controls the stimulation of pancreatic beta-cells (de Oliveira, Grassiolli, Gravena, & de
Mathias, 2012). This demonstrates that early postnatal malnutrition can be linked to
autonomic nervous system imbalances later in life. These results show that further research is
necessary in determining the effects of maternal nutrition in both animals and humans.
Some researchers have been examining nutrition as a way to break the
intergenerational cycle of obesity. In a recent review article, one author analyzed articles on
prenatal nutrition and obesity to compare different methods for improving maternal and fetal
outcomes (Muhlhausler, Gugusheff, Ong, & Vithayahil, 2013). The authors began by stating
that increased fat, caloric, and sugar intake, especially combined with micronutrient
deficiencies, can lead to metabolic disease in children. The author found few studies on
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nutritional interventions in pregnant women, but suggested that future research focus on low
glycemic index diets and diets with maternal nutrient supplements and omega- 3- fatty acids.
Excessive gestational weight and high prepregnancy body mass index can negatively
affect birth outcomes. One meta-analysis conducted by researchers at Chongquing Medical
University in China analyzed the effects of excessive maternal weight gain during pregnancy
on children. The researchers included twelve cohort studies, and showed that the risk of
childhood overweight/obesity was significantly associated with excessive gestational weight
gain (Tie et al., 2014). Low income women and women of color are disproportionately
overweight and obese. Around sixty percent of women gain more than the Institute of
Medicine recommends for gestational weight gain. Studies have shown mixed results for
dietary and other behavioral interventions designed to reduce gestational weight gain. Other
studies have focused on the relationship between chronic stress, high gestational weight gain,
and depression among low income women. In a study of overweight low income pregnant
women in the San Francisco Bay Area, researchers asked women about their lives to find out
what interventions would be most effective for healthy gestational weight gain (Thomas et
al., 2014). The researchers focused on asking questions about the women’s concerns about
gestational weight gain, things that stressed them out, and what they would suggest for an
intervention. A major source of stress for these women was lack of adequate food or housing,
as well as stress related to relationships. Pregnancy was also a significant stressor, and the
women worried the most about their ability to take care of another child. The women also
expressed uncertainty about the appropriate amount of gestational weight to gain, and also
felt defeated about being able to gain an appropriate amount of weight. Most of the women
said that they used eating as a coping mechanism from stress. The women were receptive
8

toward an intervention that targeted stress during pregnancy. These findings suggest that
obesity interventions need to include more than just diet and exercise advice. Mindfulness
and other stress reduction techniques can have a positive impact on healthy weight gain in
pregnancy for women and lead to improved mental health. Further trials should look into the
efficacy and effectiveness of interventions designed to reduce stress in low income pregnant
women (Thomas et al., 2014). This study shows that women benefit from the support of a
group in dealing with chronic stress during pregnancy. Support groups have also been shown
to be effective in weight loss, and can lead to improved maternal health outcomes.
Pharmacists can foster support groups by providing information for women who may benefit
from them. The pharmacy is a major place that women purchase prenatal vitamins, and
pharmacists can use this to spread information about resources available for pregnant
women. In addition to sharing information, pharmacists could work with support group
facilitators to inform women about medication questions they may have during pregnancy.
Gestational Diabetes
Gestational diabetes is another major health problem that affects pregnant women.
Gestational diabetes lacks standard guidelines for diagnosis; so many women do not receive
the treatment they need for optimal birth outcomes (Karagiannis, Bekiari, Manolopoulos,
Paletas, & Tsapas, 2010). There is not a firm cutoff for gestational diabetes, and adverse
effects due to excess glucose have been observed in women not diagnosed for gestational
diabetes (Poolsup, Suksomboon, & Amin, 2014). A study conducted in Norway showed a
connection between high fasting plasma glucose levels and increased risk of macrosomia.
Women with a BMI of 27 or greater and a high increase in plasma glucose levels were 4.5
times more likely to have a macrosomic newborn (defined as 9.24 or more pounds).
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Undiagnosed gestational diabetes can have detrimental effects on offspring and must be
systematically diagnosed and treated for optimal birth outcomes. Another study conducted in
Sweden compared birth outcomes in women with gestational diabetes, women with impaired
glucose tolerance, and women with normal glucose tolerance (Anderberg, Källén, & Bentorp,
2010). The researchers found that women who with impaired glucose tolerance had a greater
risk of complications associated with gestational diabetes than women with normal glucose
tolerance. The women with gestational diabetes and impaired glucose tolerance had a higher
risk of hypertension during pregnancy, induction of labor, large for gestational age infant,
and use of the neonatal intensive care unit (Anderberg et al., 2010). This study illustrates how
impaired glucose tolerance during pregnancy can cause complications, even if the level of
impairment is not severe enough to be classified as gestational diabetes.
One study analyzed the prevalence of metabolic disorders among infants born to
women with gestational diabetes (Boney, Verma, Tucker, & Vohr, 2005). The researchers
followed children born at appropriate weights for gestational age, and large for gestational
age who were born to women who were either obese or normal weight who either had or did
not have gestational diabetes. The researchers documented the children’s body mass index,
blood pressure, blood glucose to blood insulin ratios, HDL levels, LDL levels, and
triglyceride levels at ages 6, 7, 9, and 11. The researchers found that children born either
large for gestational age to either obese or diabetic mothers had an increased risk of
developing metabolic syndrome in childhood. These results suggest that obese women
without gestational diabetes may have other metabolic risk factors which can influence their
children (Boney et al., 2005). To help combat the intergenerational cycle of obesity and
metabolic syndrome, healthcare providers must work together to help women make lasting
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lifestyle changes. Pharmacists can work with other providers to insure that these women are
receiving the best possible medications for their conditions.
Women with gestational diabetes have a higher risk for gestational hypertension, fetal
macrosomia, poly-hydroamnios, and stillbirth. Having gestational diabetes increases the risk
of developing gestational diabetes during subsequent pregnancies. Gestational diabetes also
increases the risk of developing type two diabetes after pregnancy. In a recent meta-analysis
on the effects of treatment for gestational diabetes, researchers found that women treated for
their gestational diabetes had lower chances of poor birth outcomes than women with
gestational diabetes who were untreated. The meta-analysis found that women who were
treated for gestational diabetes had a reduced risk of macrosomia, large for gestational age
births, shoulder dystocia, and gestational hypertension, without being at a higher risk of
being born small for gestational age (Poolsup et al., 2014).
One way to manage gestational diabetes is proper nutrition. Nutritional counseling
can improve maternal and fetal outcomes by controlling blood sugar. Women with
gestational diabetes are advised to consult with a nutritionist at least three times during their
pregnancy. In a study conducted in the United Arab Emirates, women in their third trimester
of pregnancy with gestational diabetes were compared with women in their third trimester
without gestational diabetes (Ali, Jarrar, Sadig, & Yeatts, 2013). The researchers focused on
testing nutritional knowledge, habits, and number of consults with a registered dietician.
22.3% of the women with gestational diabetes did not meet with a registered dietician at all
during their pregnancy, and only 12% met with a registered dietician three or more times
during their pregnancy. Both women with and without gestational diabetes had similar
knowledge about foods that increase blood sugar. Both groups of women had similar diets,
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with women with gestational diabetes eating more dairy products and women without
gestational diabetes consuming more fruit and fruit juices. Women knew relatively little
about the role of carbohydrates in raising blood sugar (Ali et al., 2013). This gap in
knowledge indicates that women with gestational diabetes should be referred to a dietician
earlier in their pregnancies so they can be educated on proper nutrition during pregnancy.
Pharmacists can care for women with gestational diabetes by providing clinical care
for patients in a hospital or by running special clinics for women with gestational diabetes. In
a prospective, longitudinal, randomized control trial, researchers in the United Arab Emirates
studied how pharmacists can improve health outcomes for women with gestational diabetes
(Elnour, Mugammar, Jaber, Revel, & McElnay, 2008). The study was conducted over
eighteen months and 165 women were recruited to the trial, with 99 being in the treatment
group and 66 in the control group. Women in the treatment group received structured
pharmaceutical care services, including education and introduction to intense selfmonitoring, and women in the control group received traditional treatment. Women in the
treatment group had significant improvements in knowledge of diabetes, health related
quality of life, control of plasma glucose, maternal and neonatal complications (Elnour et al.,
2008). Maternal health complications in this study included pre-eclampsia, eclampsia, severe
hyperglycemic episodes, and need for Caesarian sections. Neonatal complications in this
study included neonatal hypoglycemia, respiratory distress at birth, hyperbilirubinemia, and
large for gestational age births. The improvements in all of these categories showed that the
inclusion of pharmaceutical care in the management of gestational diabetes can improve
maternal and neonatal outcomes. Pharmacist run clinics could be a possibility in improving
prenatal pharmaceutical care for women with gestational diabetes. Pharmacists in the United
12

States can do glucose tests, and monitor medication for women (Evans & Patry, 2004). By
having a pharmacist run clinic, women can have more access to high quality healthcare.
Other clinics focusing on focusing on diseases states like diabetes, diyslipidemia, and
metabolic syndromes have pharmacists working alongside other professionals to provide care
to patients. A clinic for gestational diabetes could follow this collaborative practice model.
However, this access to specialized clinics can be restricted due to cost barriers and
geographical constraints, especially if the clinic is in a rural area. Further research is needed
on how to implement cost effective, pharmacist run clinics for women with gestational
diabetes.
Hypertension
Hypertensive disorders of pregnancy include preeclampsia and gestational
hypertension. Gestational hypertension is defined as new onset hypertension that develops
beyond twenty weeks of gestation, and preeclampsia is defined as new onset hypertension
that begins beyond twenty weeks of gestation accompanied by proteinuria (Callaway,
O’Callaghan, & McIntyre, 2009). These conditions are similar to one another, but
preeclampsia more severe than gestational hypertension. Obesity and hypertensive disorders
of pregnancy share common underlying causes, and obesity has consequences that can lead
to the development of these disorders.
Gestational hypertension and preeclampsia can cause adverse health outcomes for
infants. Preeclampsia is a hypertensive condition in pregnancy that decreases placental blood
flow and can lead to intrauterine growth restriction in the second half of pregnancy
(Callaway et al., 2009). Preeclampsia occurs in about 2-3% of pregnant women and is
responsible for around 15% of all preterm births, which can lead to infant morbidity and
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mortality. Some risk factors for preeclampsia include high BMI, chronic hypertension,
diabetes mellitus, and family history of preeclampsia. Health care providers have advised
some women to take vitamin C and E supplements to prevent these conditions (Rahimi,
Nikfar, Rezaie, & Abdollahi, 2009). A meta-analysis conducted by researchers at the
University of Medical Sciences in Tehran, Iran investigated the effects of vitamin C and E
supplements on maternal and neonatal health outcomes. The outcomes of interest were
gestational hypertension, preeclampsia, preterm delivery, small for gestational age infants,
and low weight births (Rahimi et al., 2009). The researchers pooled seven studies for this
meta-analysis, with 2982 pregnant women at risk for preeclampsia receiving combined
vitamin C and E supplements and 2987 pregnant women at risk for preeclampsia receiving
placebo treatments. The meta-analysis showed that not only did the supplements not improve
maternal and fetal health outcomes, women who received the supplements had a higher risk
of gestational hypertension and low birth neonates than women who received placebo
treatments.
Maternal hypertension can affect neonatal pain responses. Hypertension has been
linked to impaired pain response in adults, but the subjective nature of pain reporting has
made it difficult to establish a definitive relation. In one study, eighty infants were videorecorded as they received a vitamin K injection. The videos were then shown to professionals
who were experienced in gauging infant pain responses, and were rated on appearance. The
families of the infants also completed a family medical history. Infants born to mothers with
hypertension had shorter crying times and lower facial grimacing scores than infants born to
mothers without hypertension (France, Taddio, Shah, Page, & Katz, 2009). These finding
illustrates that pain responses in infants can be affected by maternal hypertension.
14

Anemia is another blood disorder that can affect pregnant women. Iron
supplementation can be used to improve birth outcomes in anemic women. Anemia during
pregnancy can have negative effects like preterm delivery, fetal growth restriction, and low
birth weight, all of which can increase the risk of infant mortality. Researchers suggested that
women at risk for anemia should take iron or iron-folic acid supplements during childbearing
years to lower the risk of adverse birth outcomes. However, too much iron given to
nonanemic women could increase the risk of gestational diabetes and preeclampsia (Scholl,
2011). One cohort study followed how heme iron intake and non heme iron intake can affect
the risk of pregnant women developing gestational diabetes (Qiu et al., 2011). Heme iron is
exclusively present in hemoglobin and myoglobin from animal sources. It is more
bioavailable than nonheme iron, and has also been associated with a higher risk of
developing Type 2 diabetes in the general population. Nonheme iron is found in grains,
vegetables, fruits, vegetables, beans, and dairy products. In this study, women who consumed
higher levels of heme iron had a higher risk of developing gestational diabetes. Women with
the highest level of heme iron intake had at least a twofold risk increase over women who
reported consuming lower levels of heme iron. This finding was after controlling for
maternal age, prepregnancy BMI, parity, and other dietary factors (Qiu et al., 2011). These
findings show that the levels of maternal iron as well as the origin of dietary iron could affect
the risk for gestational diabetes and other complications. A recent review of literature
published on iron and pregnancy showed that iron status in utero can have effects on brain
development. The fetus is not able to get all of its iron from an iron deficient mother, which
can cause issues in development. The researchers showed that multiple births, teenage
pregnancy, obesity and gestational diabetes can all affect maternal iron stores differently, and
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that further research was necessary to see how iron status can affect developing fetuses (Cao
& O’Brien, 2013). These findings show that health care providers should make sure that
women have adequate levels of iron before and during pregnancy. A study of women in
Romania showed that prenatal education can lead to higher levels of multivitamin, iron, and
folic acid supplementation (Popa et al., 2013). Nutritional knowledge was highly correlated
with vitamin supplementation. With this in mind, healthcare providers could focus on
educating women about prenatal vitamins to improve public health.
Postpartum
Postpartum maternal care for women with obesity, hypertension, and diabetes is an
area that can be overlooked by healthcare providers. In a Swedish study, women with body
mass indices between 25 kg/m2 and 35 kg/m2 who were 10-14 weeks postpartum were
enrolled to test how diet and exercise affected postpartum weight loss (Brekke et al., 2014).
The women were divided into four groups with interventions of diet, exercise, both diet and
exercise, or control. The women assigned to the diet intervention group consulted with a
registered dietician and followed a diet of 500 calories less per day than they usually ate. The
exercise group had a meeting with a physical therapist and walked four times a week for
forty five minutes each time. The combined group received both of these interventions, and
the control group was instructed to live as they usually do. The groups were evaluated after
twelve weeks, and again after one year. The women who followed the diet intervention
programs had significant and sustained weight loss, as well as improved cardiovascular risk
factors, including waist circumference and lower concentrations of blood lipids and fasting
blood insulin. The women with the exercise intervention did not have different health
outcomes than the women in the control group (Brekke et al., 2014). This study suggests that
16

nutrition plays a vital role in postpartum healthcare. Visits with a registered dietician may
improve postpartum health outcomes for mothers.
Breastfeeding is another variable that can affect postpartum weight retention. In a
study conducted of mothers enrolled in North Carolina’s WIC program, women who
breastfed reported greater weight loss than women who did not breastfeed. The women were
weighed at three months postpartum and again at six months postpartum. At three months,
the weight loss was the same among women who breastfed, formula-fed, or both breastfed
and formula-fed their infants. However, at six months, women who breastfed lost more
weight than women who did not breastfeed. These results were still significant after
controlling for pre-pregnancy BMI, race, education, and gestational weight gain (Krause,
Lovelady, Peterson, Chowdhury, & Østbye, 2010). Low income women are
disproportionately affected by obesity and related health problems, which can be positively
affected by breastfeeding. In previous studies of WIC programs, women were polled about
their knowledge and attitudes about breastfeeding (Krause et al., 2010). Women enrolled in
WIC were well informed about the benefits of breastfeeding but still had lower rates of
breastfeeding compared to other mothers. The study also found that attitude barriers like
perceptions of breastfeeding as limiting and being embarrassed about public breastfeeding
inhibited more women from breastfeeding than structural barriers, like returning to work.
This finding suggests that health professionals should reinforce the benefits of breastfeeding
for postpartum health. Lactation experts can also talk to women about their breastfeeding
concerns, and share ideas to help with attitude barriers. Lactation experts, as well as
nutritionists, are important to insuring positive health outcomes in pregnant women.
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The prevalence of mental illness has been rising in the United States, which leads to
many women becoming pregnant while on behavior altering medication. Selective serotonin
reuptake inhibitors are the most frequently prescribed medication to treat depression (Domar,
Moragianni, Ryley, & Urato, 2012). Animal studies have shown that these medicines can
effect neonates, since serotonin is used in many biologic processes including neurogenesis,
neuron differentiation and regulation of food intake. One study conducted in Denmark
observed the differences in children’s weight at age seven based on prenatal exposure to
SSRIs. The study observed mother-child dyads, and recorded the mother’s use of SSRIs and
history of mental illness. In 127 pairs, the mother used SSRIs during pregnancy, in 490 pairs,
the mother reported a history of mental illness but no use of SSRIs, and 35,568 pairs reported
no maternal use of SSRIs or history of mental illness. Maternal use of SSRIs was not shown
to have a significant effect on children’s weight at age seven. However, when children were
separated into male and female, male children of women who had used SSRIs had an
increased risk of being overweight compared to other children. Female children of mothers
with a history of mental illness but no SSRI use were also had an increased risk of being
overweight (Grzeskowiak et al., 2013). These results show a possible sex specific differences
in how children are affected by SSRI use and maternal mental illness. Pregnant women
frequently quit taking their prescribed medications because they believe that the medication
would harm their unborn children (Lupattelli, Spigset, & Nordeng, 2014). One literature
review conducted by researchers in Boston showed that SSRIs reduced infertility treatment
efficacy in women. The literature review also showed that SSRIs were linked to increased
risks of miscarriage, birth defects, preterm birth, persistent newborn pulmonary hypertension,
and possible long term neurobehavioral effects (Domar et al., 2012). The study found that
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SSRIs did not improve any pregnancy outcomes and that psychotherapy could be beneficial
in treating depressive symptoms in women hoping to become pregnant. Some selective
serotonin reuptake inhibitors can increase the risk of hypertension in pregnant women (de
Vera & Bérard, 2012). However, withdrawals from SSRIs and untreated depression and
anxiety can have detrimental effects on the fetus. Pharmacists and mental health care
providers need to meet with pregnant women and nursing mothers to discuss how to manage
their medications to provide the best possible scenario for mother and child.
Vitamin D deficiencies have been linked to mental illness and other health conditions
in postpartum women (Dror & Allen, 2010). In a study conducted in Finland, women who
consumed the daily recommended amount of vitamin D were less likely to have children with
type 1 diabetes. The children were followed up to one year of age, and were given vitamin D
supplements (Hyppönen, Laara, Reunanen, Jarvelin, & Virtanen, 2001). The study found that
vitamin D supplements in women and children with suboptimal vitamin D levels led to
reduced risk of type 1 diabetes in the children. Finland has the highest worldwide incidence
of type 1 diabetes, which some attribute to suboptimal levels of vitamin D (Hyppönen et al.,
2001). Another study conducted on the importance of vitamin D during pregnancy showed
that many pregnant women had suboptimal levels of this vitamin. Vitamin D is used by the
body in skeletal development and cell differentiation. Lack of vitamin D can lead to poor
bone mineralization, rickets, lower respiratory infections, and suboptimal brain development
(Dror & Allen, 2010). This study clearly showed how pregnant women should be vigilant
about their vitamin D levels. In a cross sectional study conducted in Australia, researchers
showed that behavioral patterns were not as predictive as ethnicity, season, and BMI in
determining vitamin D deficiency (Perampalam et al., 2011). Since most of the women
19

included in the study had at least one risk factor for low vitamin D, researchers suggested
that women should take higher levels of vitamin D in pregnancy.

Limitations of the Current Literature
The most significant gap I saw in the literature is that there were very few articles
dealing with testing drugs on pregnant women. Lack of research in this area means that few
drugs have been proven to be safe during pregnancy. The articles that I read encouraged
women of childbearing age to research the effects on medication on their future children
(Riley et al., 2005). However, if there is no research on this subject, finding out which
medications are safe and which are not is nearly impossible. A common recommendation for
pregnant women is to stop taking all potentially harmful medication while they are pregnant.
While this approach protects these women from unforeseen medication side effects, it might
be worse for the mother and child to be affected by the untreated disease. Pharmacists and
other health professionals need to stay up-to-date on medication safety research to provide
counseling for pregnant women with chronic diseases. Health care providers must inform
women on how to responsibly take medication while pregnant or planning on becoming
pregnant.
There were also few articles about how pharmacists can improve prenatal and
postnatal health care. During pregnancy, drug therapies must be altered to be safe for both
mother and child. However, the lack of data on medications, as well as the lack of studies on
ways to care for these patients, has led to gaps in protocol for how to care for pregnant
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women with chronic diseases. Without protocols, women may not receive the highest quality
care, which puts both them and their children at risk for complications.
Further research is needed to determine how to proceed with pharmaceutical
treatments for pregnant women. There also needs to be more emphasis on forming an ideal
health care team to care for pregnant women and new mothers. Instead of different specialists
seeing the same people in different locations, health care professionals need to take a
population health based approach to caring for pregnant women. In the remainder of this
thesis, I will explore how pharmacists can be part of an effective team for optimizing birth
outcomes.
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INTERVIEWS
Methods
To gain perspective on how pharmacists provide prenatal care for women with
chronic diseases, I interviewed pharmacists working in chain stores, independent pharmacies,
clinics, and hospitals in either Mississippi or Memphis, TN. During these interviews, I asked
the pharmacists about how they manage the medications for pregnant women with chronic
diseases, how they worked with other healthcare providers to provide care, and what could be
improved with prenatal pharmaceutical care for women with chronic diseases. The complete
list of interview questions is included in Appendix I. I was referred to some of these
pharmacists by my thesis advisors, and some of the pharmacists referred their colleagues to
be interviewed. During these interviews, I asked about their professional experiences, their
previous experiences of treating pregnant women with chronic diseases, how they think
pharmacists can improve prenatal care for these women, and how pharmacists can work with
other healthcare professionals to provide this care. Pharmacists were recruited over email,
and interviews were conducted over the phone. The interviews were audio recorded for
accuracy, and the complete results for these interviews can be found in Appendix II. Their
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insight provided ideas about how pharmacists could provide a higher quality of care to these
patients.
I took handwritten notes during the interview, then listened to the recordings and took
additional notes. I then typed these notes and organized for by pharmacist for each question.
After analyzing the responses for each pharmacist individually, I compiled the results, listed
each pharmacist by letter, and saw the trends between pharmacists for answering each
question. For each question, I grouped similar responses together, and recorded any
significant differences between responses. Then, I looked at common answers to see
overarching themes in the results.
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ANALYSIS
I interviewed a total of thirteen practicing pharmacists for this thesis. Eleven of the
pharmacists I interviewed currently work as pharmacists in Mississippi and two of them
work as pharmacists in Memphis, TN. The Mississippi pharmacists practice primarily in
North Mississippi, and none of them practiced further south than Jackson, MS. All but one of
the pharmacists had experience working in retail pharmacy, whether independent or chain.
The pharmacists agreed that most of their encounters with pregnant patients took place in a
retail pharmacy setting.
At the time of the interviews, six of the pharmacists were working at ambulatory
health clinics, and also taught at the University of Mississippi. Four of the pharmacists I
interviewed worked in retail pharmacists, with two of the pharmacists in chain retail
pharmacies in Memphis, Tennessee, and two in compounding retail pharmacies in Jackson,
Mississippi. Two of the pharmacists worked in hospitals in Mississippi. One pharmacist
worked in providing medications for assisted living facilities in North Mississippi.
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The pharmacists thought that lack of education on medications was a major issue
faced by pregnant women and breastfeeding mothers. Several pharmacists agreed that
pregnant women are not given enough education on their medications. Pregnant women have
different medication requirements than other populations. Data on medication safety for
pregnant patients can be difficult to interpret for people who are not health professionals.
According to these interviewees, pharmacists need to make sure that pregnant women
understand what medicines are safe during pregnancy and how to take their medications
correctly. Some pharmacists proposed making a database or handout on which drugs are safe
for pregnancy. These resources could be distributed in community pharmacies.
Patient education for patients with gestational diabetes is critical. If a woman has no
history of diabetes, she may not know how to test her blood glucose or self-administer
insulin. The pharmacists I interviewed suggested that pharmacists could assist other
healthcare providers by educating women with gestational diabetes on how to test their blood
glucose and self-administer insulin. Pharmacists can also work with dieticians to help women
manage their blood glucose. The pharmacists I spoke to said that pharmacists working in
chain retail pharmacies may not have time for individual patient counseling appointments.
Chain retail pharmacies focus on distributing as many medications as possible to maximize
revenue. If pharmacists are not compensated for patient consultations, then the chain may
discourage these interactions. Pharmacists recommended informing pregnant women with
Type 2 diabetes about how their disease state may change during pregnancy. Patients may
experience greater fluctuations in blood sugar during pregnancy. Since many oral antidiabetic
medications are discouraged during pregnancy, pharmacists need to make sure that they can
manage their diabetes without these drugs. Dieticians can provide guidelines for stabilizing
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blood glucose through proper nutrition. Interdisciplinary collaboration can provide clear
treatment plans for patients to follow.
The interviewed pharmacists were divided on suggesting interventions for obese
pregnant women. Retail pharmacists, especially those working in chain setting, felt that
offering unsolicited advice to obese pregnant women could be seen as offensive. These
pharmacists expressed concern that offering advice could hurt the pharmacy’s business and
recommended only giving advice if women specifically asked. The clinical pharmacists
advised speaking with obese pregnant women about healthy weight gain guidelines, and
working together to make sure that their pregnancy was as healthy as possible. Clinical
pharmacists also recommended working dieticians and other health professionals to provide
the best care for each patient. The difference in recommendations could stem from the
differences in retail and clinical pharmacy practice. Clinical pharmacists spend time one on
one with each patient and build relationships that allow them to give patient specific advice.
Retail pharmacists see many patients every day and may not have a close enough relationship
with their patients to suggest individual interventions. These results indicate that more obese
women should consult with clinical pharmacists to receive individual interventions.
When treating pregnant and breastfeeding patients, pharmacists said that they made
sure to double check for medication safety. The interviewed pharmacists recommended that
these patients take as few medications as possible since most medicines do not have safety
data for pregnancy. Patients should also be advised to take birth control if they are prescribed
medications that have potentially teratogenic effects. Health care providers can work with
patients to provide treatment plans that include fewer medications.
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Pharmacists need access to patient health records to know how to treat pregnant
patients who have previously had a low weight or preterm birth. Many of the pharmacists
stated that these cases were outside of their scope of practice. The other pharmacists said that
they would need more information before they could treat these patients, since there are
many possible causes for these conditions. Patient medical histories are vital to
understanding the causes for these conditions. Some possible causes for low weight birth that
the pharmacists discussed were malnutrition, nicotine consumption, genetics, and lack of
prenatal care. The pharmacists recommended that these women keep all prenatal care
appointments.
Limited access to high quality healthcare is another issue for pregnant patients. Since
Mississippi is mostly rural, healthcare access can be limited by geographic barriers. These
geographic barriers can discourage women from seeking prenatal care. Some solutions that
have been proposed are having traveling health care providers practice in several rural areas,
as well as group interventions to lower financial cost for patients. Group interventions can
also benefit patients by providing a support system. Pharmacists recommended group
interventions as a way to reinforce individual prenatal care.
Studying population health trends can assist providers in finding issues that can be
treated in a group setting. All of the clinical pharmacists knew the meaning of “population
health”, while many of the community pharmacists did not. All of the pharmacists had
studied health trends in the population they served. This suggests that pharmacists
incorporate population health into their practice, even if they did not know the specific term.
Pharmacists recommended educating groups on health issues like medication safety and
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management. They also suggested partnering with other community organizations and
programs like WIC and religious groups to reach a wider audience.
Prenatal care is typically given in a physician’s office. However, if a woman does not
have the resources to see a physician for all prenatal Pharmacists were asked about the best
setting for women to receive prenatal care. Most pharmacists agreed that the best place for a
woman to receive prenatal care was somewhere she felt comfortable. They also agreed that
women needed to receive care from a provider who has their complete medical records. A
couple of the pharmacists said that prenatal care could be given in a group setting, but the
majority said that one on one interventions were still the best. Pharmacists said that retail
pharmacies were not optimal for prenatal care because there were no private counseling area.
However, clinical pharmacies and community health centers can be sites for prenatal
counseling.
Gaps in prenatal and postnatal care for patients can negatively affect patient health.
The pharmacists said that lack of patient knowledge about prescription and over the counter
medications is a major gap in patient care. Patients do not have a clear source of information
on medication safety during pregnancy. Pharmacists should be proactive about advertising
their services as medication experts. Some pharmacists recommended for patients to schedule
an appointment with their pharmacist to go over how pregnancy affects medication use. They
also recommended giving patients handouts on safe medications in pregnancy, as well as
verifying patient’s understanding of how to use their medications.
Pharmacists recommended more communication among health care professionals to
improve care for pregnant women with noncommunicable diseases. The current model for
healthcare usually involves a patient seeing several different health professionals in different
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offices. This model can discourage interprofessional collaboration and potentially cause gaps
in patient care. Providers caring for the same patient may not know one other’s area of
expertise or all of the services each professional can offer. Pharmacists suggested greater
team interaction to promote more unified health care for these patients. Team members need
to meet together to discuss their individual strengths and training. Then they can develop a
plan for patient care to make sure that all patient needs are being met. While this approach
will require more time to plan, it could improve patient outcomes.
All of the pharmacists I spoke to advocated for more communication with providers
and patients to provide high quality healthcare. They also said that pharmacists should be
more involved in educating pregnant women about their prescription and over the counter
medications. The pharmacists also agreed that pharmacists need to communicate more with
other healthcare providers to make sure that other providers know what pharmacists can add
to a healthcare team.
The clinical pharmacists I spoke with said that their clinics did not treat pregnant
patients. The women are cared for by an OB/GYN as long as they are pregnant and
breastfeeding. This scenario protects clinic health care providers from liability, but burdens
the OB/GYN with health conditions that may be outside their scope of practice. In addition to
changing the women’s healthcare team, women often have to change medications while
pregnant. Pharmacists could assist women by double checking that their medicines are safe.
By keeping the woman’s pharmacist as a constant provider, the woman has at least one
permanent member of her healthcare team. Having the same pharmacist throughout this
experience will also smooth the transition between healthcare teams.
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Most of the pharmacists I talked to agreed that education was important for every step
of prenatal care. However, pharmacists are limited in their patient interactions by time
constraints in retail chain pharmacies. Pharmacists may also not want to offend patients by
providing unsolicited advice. Patients may respond better to advice from clinical pharmacists
since clinical pharmacists have more time to spend on patient care. Patients may also trust
clinical pharmacists more, since they see the same pharmacist for health care.
Another area for improvement is communication between pharmacists and other
healthcare providers. This can make communication more difficult and cause gaps in patient
care. Providers need to effectively communicate and divide responsibilities to improve
patient care. Pharmacists need to advertise their skills to other healthcare providers to make
sure that they are providing the best possible care. Pharmacists can inform patients about
appropriate medication choices, as well as make sure that their over-the-counter medicines
are safe.
None of the pharmacists I spoke to felt that they were qualified enough to counsel
pregnant women with chronic diseases. The pharmacists also said that there were no
continuing education credits that they were aware of offered to teach pharmacists about fetal
and maternal health. Pharmacists need to be offered training in this area so that they can be
effective team members for treating pregnant women with chronic diseases.
There are few treatment guidelines given for pregnant women and new mothers,
especially concerning hypertension and diabetes. The pharmacists I spoke to recommended
healthy weight gain and proper nutrition to improve birth outcomes. However, this is
unfeasible for many women. Food deserts in rural areas can make it difficult to find
nutritious food. Financial constraints can also limit patient access to nutritious food.
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Pharmacists and other health care providers need to work together to provide feasible diet
plans for pregnant women with chronic diseases.

CONCLUSION
Discussion
The interview portion of this study was limited by a relatively small sample size of
pharmacists who were available to be interviewed. Nonetheless, by combining the systematic
literature review with the experiences and views shared by pharmacists in the interviews, the
overall study helped to shed light on the current roles and challenges to engaging pharmacists
in maternal health care. Additionally, this research resulted in recommendations for engaging
pharmacists.
Future Research
To build on this thesis, future research should focus on interviewing pregnant women
on gaps in their prenatal care, especially as they concern the pharmacy practice. Other
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healthcare workers should also be interviewed about how pharmacists could become a more
active member of the prenatal health care team. Two additional areas for research are the
effects of obesity on children and how to improve the birth outcomes of obese women.
In the future, I hope that someone will develop a program to include pharmacists in
care for pregnant women with chronic diseases. I do not know of any programs that currently
exist that include pharmacists in this capacity. Having a pharmacist on the team to support
the other providers and provide advice on drugs will be an asset to women. A clinic with a
pharmacist in residence will help women navigate through pregnancy and beyond.
Developing a continuing education for pharmacists about prenatal care would
improve pharmacist’s knowledge of how to treat pregnant women. This could be developed
with the assistance of an OB/GYN, and provide guidelines on how to act in common prenatal
care situations. By educating community pharmacists about prenatal care, they will be better
equipped that handle questions from the public.
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APPENDIX I
Pharmacist Interviews Questions
1.

To start, please tell me about your work as a pharmacist.

2.

What do you see as the greatest health challenge facing pregnant women?

3.

What do you see as the role of pharmacists in regard to prenatal and postnatal care for

these women?
4.

Are there any special approaches for mothers who are (probe for each): obese, have

Type II diabetes, have gestational diabetes, have had a preterm birth (<37 weeks gestation),
have had a low-weight birth (<2,500 grams)?
5.

How do you manage the medications of a pregnant woman/breastfeeding mother

differently than another patient?
6.

How do you think that pharmacists can improve prenatal care?
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7.

Have you heard the concept “population health”? What does this mean to you as a

pharmacist?
8.

How can a population health mindset improve prenatal and postnatal pharmaceutical

care?
9.

How can pharmacists work with other health care providers to best provide prenatal and

postnatal care?
10. From your perspective, what is the best environment for a woman to receive prenatal and
post-natal care? (community health clinic, hospital, neighborhood pharmacy, or other)
11. What are the major gaps you have observed in prenatal and postnatal care?
12. Do you have any recommendations for non-pharmacists concerning how they can better
interact and work with pharmacists to provide maternal health care?
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APPENDIX II
Coded Results
1. Pharmacist A currently works in the neonatal intensive care unit at a hospital and has also
had experience in retail pharmacy. He focuses on antibiotic fluids and nutrition.
Pharmacist B has worked in both chain and independent retail settings. She currently works
in a university as a clinical pharmacist and specializes in tobacco cessation.
Pharmacist C works in a university as a clinical professor. She also works with physicians
and nurse practitioners in a rural clinic focusing on cardiometabolic disorders, diabetes.
dyslipidemia, hypertension, and smoking cessation. She completed a community pharmacy
residency where she worked with immunizations in a school clinic, community pharmacy in
both a chain and independent setting. She has also worked with other professors on
developing medicine synchronization programs so patients can receive all of their
medications at one time.
Pharmacist D works as a clinical pharmacist in several different clinics in rural Mississippi.
She also works at a chain community pharmacy. In one clinic, she works with a physician
and nurse practitioner to monitor patient’s A1C, blood pressure, and cholesterol. She also
counsels patients on tobacco cessation. These programs are funded by the CDC. She counsels
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diabetic patients on medication therapy management and self-monitoring resources, like
glucometers. She educates patients on side effects and complications, and also uses a variety
of approaches like ACE inhibitors, carbohydrate counting, exercise, and statins to control
these conditions. She gives vaccines, performs eye and foot exams and waist circumference
tests and makes recommendations to the providers for treatments.
Pharmacist E works as a hospital pharmacist in Mississippi.
Pharmacist F works in clinical practice in an urban setting. She works in a diabetes clinic that
cares for patients with diabetes, hypertension, and weight issues. She provides medication
therapy management services, answers medication questions, and educates patients about
their condition. She has also worked in providing medication therapy management in both a
chain and independent retail setting. Before working in the diabetes clinic, she worked in a
metabolic clinic and a family medicine clinic. She works health fairs in the Mississippi Delta.
Pharmacist G currently works as a retail pharmacist in a suburban area. He has previously
worked with a home health pharmacy group that delivered nursing home care. He also
worked with hospital and retail pharmacies in the US military, as well as working as a poison
control pharmacist and a 911 specialist.
Pharmacist H has been a pharmacist for fifteen years and has worked in a hospital pharmacy,
a retail pharmacy and in pharmacy contracting. She has seen most pregnant women in a retail
setting.
Pharmacist I has a wide experience in clinical pharmacy and has worked with patients with
diabetes, hypertension, dyslipidemia, asthma, and chronic kidney disease. She has reviewed
medicines and made recommendations for patients. She now educates patients on disease
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states and modifications in a clinical setting. She also helps students transition to adult care
insurance with medications and managing care.
Pharmacist J has worked in a suburban chain retail pharmacy where he fills prescriptions,
monitors drug interactions, checks on inaccurate dosing and bad prescriptions. He also
counsels customers on medications, directives and side effects. He also provides economic
counseling for patients to help provide more affordable medications.
Pharmacist K currently works as a compounding pharmacist in an urban area. She has
worked in an independent retail pharmacy, hospital and nursing home as well as providing
home IV services. She compounds bioidentical hormones as well as transdermal treatments
and creams.
Pharmacist L has been practicing for fifteen years in a variety of settings. He has worked in a
hospital pharmacy and with research and development in industry. He currently works in a
university and as a clinical pharmacist with patients with major diabetes, thyroid disease,
hypertension, dyslipidemia, and occasionally pregnant patients with type 1 or 2 diabetes.
Pharmacist M currently works as a pharmacy manager and distributes medicines to nursing
homes and assisted living facilities. He has also worked in chain retail pharmacy.
2.

The pharmacists I interviewed mostly agreed that lack of education on medication use

during pregnancy was the greatest health challenge facing pregnant women. Pharmacists D,
E, F, G, and M recommended that community pharmacists should instruct patients on which
medications are safe for pregnancy. Pharmacists can also dispel myths surrounding
medications during pregnancy. The pharmacists also stated that lack of knowledge about
over the counter drugs and supplement use during pregnancy can be dangerous to women and
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their children. Pharmacist G recommended creating a database about drug safety in
pregnancy with nontechnical language. He believed that technology was a valuable tool for
education on medications during pregnancy. Pharmacist I said that patients are uninformed
about health struggles in pregnancy and do not ask their healthcare provider enough
questions. She recommended that pharmacists be more involved in checking the safety of
prescription medications for these women as well as offering prenatal pharmaceutical
counseling. Pharmacist K who had worked in a variety of roles said that nonlife threatening
but painful conditions like hypertension, diabetes, reflux, and hemorrhoids are the biggest
problem facing pregnant women. She recommended educating women on what to expect
from their bodies during pregnancy, and how to deal with new health challenges that they
may face. By giving women more information about the safety of medications during
pregnancy, women can have better control of their health.
Another common theme in the pharmacists’ responses was the importance of
management of chronic disease states before becoming pregnant. Pharmacist L who worked
with diabetes patients recommended therapeutic lifestyle changes for women to have a
healthier pregnancy. Pharmacist J agreed with this view and added that proper sleep, diet,
and exercise are vital to a healthy pregnancy. He advised women to watch their weight while
pregnant and exercise safely to have better birth outcomes. Pharmacist M added that lifestyle
modifications can be used to manage patients with prehypertension so that they do not have
to go on prescription medication.
Pharmacist B who works in North Mississippi said that unequal access was a major
challenge facing pregnant women in this state. Depending on location, women can have
access to affordable, convenient healthcare or not. Pharmacist C agreed that limited
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healthcare access was a major problem, especially in women with chronic diseases living in
geographically isolated areas. She suggested that practitioners should travel to rural areas to
offer treatment to patients who would otherwise not have access. She also emphasized the
importance of services like family planning, and pregnancy preparation. Pharmacist H said
that lack of access to healthcare can lead women to not seeking out prenatal care. Some
women also may not find out about their pregnancy until three or four months along, which
can prevent them from seeking early prenatal care. Pharmacists and nurse practitioner could
take a more active role in educating isolated patients in their area of practice.
Pharmacist A stated that illicit drug use was a huge problem in the neonatal intensive
care unit. Heavy drug use causes premature delivery, and most babies in the intensive care
unit are premature. He stated that prescription drugs were not nearly as much of a problem as
legal drugs like nicotine and ethanol.
3.

Most of the pharmacists agreed that educating women on the safety of their

medications was the role of pharmacists in prenatal care for women with chronic diseases.
Pharmacist B stated that pharmacists should be aware of the safety risks in all the
medications that are sold to pregnant women. Pharmacist F thought the most important role
in a community pharmacy setting was providing prenatal OTC vitamins. Pharmacists can talk
through cost effective options. Pharmacists H and M observed that most people come to the
pharmacists before the doctor for advice about prenatal care and vitamins. Pharmacist M
added that since pharmacists are accessible to patients, it is the pharmacist’s responsibility to
make sure that patients are fully educated on their medicines and do not fall through the
cracks of the healthcare system. Pharmacist J recommended counseling on proper nutrition
and selection of prenatal vitamins. He said that some nonprescription vitamins were good for
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most women. He sees around 40 pregnant women every month in his practice and they very
rarely ask for advice. Most of them receive prenatal vitamins through tenncare.
Pharmacist A thought that educating women on the safety of their medications was
the most important role of the pharmacist in providing prenatal and postnatal care for these
women. He also recommended educating women on the effects of recreational drugs during
pregnancy. He also suggested reviewing the medication list for each patient to make sure that
their drugs are in safe categories. If the patient is on antidepressants or other potentially
harmful medications, he recommended shifting their therapy to less dangerous drugs.
Pharmacist C stated that a possible role for pharmacists in prenatal and postnatal care
could be assisting providers in treating patients with serious medical conditions. She
recommended that follow ups can happen with providers and pharmacists. She also
suggested that pharmacists educate patients on both pharmaceutical and nonpharmaceutical
methods for controlling their disease states. Pharmacist F stressed the importance of open
lines of communication between healthcare providers and patients in clinical pharmacy.
Clinical pharmacists are more involved with consulting and medication therapy and focus
more intensely on patients. Pharmacist L focused on the importance of counseling diabetic
patients on the importance of optimal glucose control through diet and correct use of insulin.
Pharmacist D thought that education was important but did not do any good if
patients do not know how to use resources. Retail pharmacists are the first line of counseling
and should be proactive about asking patients if they quit birth control. Make sure women
with chronic diseases understand diet and healthy weight gain. Since time is limited to about
five minutes per visit in retail pharmacy, pharmacists should make an effort to talk to
pregnant women about their medications. Pharmacists should also be sure to note whether
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pregnant patients have gestational diabetes or Type 2 diabetes. Pharmacists should make an
effort to prevent patients from falling through the cracks.
Pharmacist E thought that pharmacists should assist in clarifying the doctor’s
instructions for the patient. He did not think that pharmacist should recommend drugs to
patients and instead recommended that pharmacists emphasize the importance of medication
adherence to patients. He also observed that supplements are not well regulated and
encouraged pharmacists to tell pregnant women to talk to a physician before starting any
supplements.
Pharmacist G thought that the pharmacist’s role in prenatal care was dealing with
minor problems, and dealing with lack of physician access. Some concerns that he raised
were the how to treat both the mother and child effectively, and how the lack of studies on
medications in children can lead to treatment issues. He said that pharmacists see many
different postnatal issues like yeast, thrush, ear and eye infections, as well as allergic
reactions in children. He recommended that pharmacists stay on top of current treatment
protocol in case of an emergency.
Pharmacist I stated that pharmacist should make an effort to see the whole patient
instead of just a list of medications or disease states. She also recommended that women not
achieving goals need to work with providers to get conditions under control. Pharmacists can
augment care and assist women to maintain control postnatally. She suggested a team based
approach composed of more than just pharmacists and doctors to optimize birth outcomes.
Pharmacist K also thought that communication and encouragement were key to a
pharmacist’s role in prenatal and postnatal care for women with chronic diseases. She also
recommended emphasizing the important of good nutrition and adherence to blood pressure
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medications. She also suggested that pharmacists should be involved in community outreach
to provide more support for these women.
4. i. Pharmacists A, E, and K stated that counseling obese pregnant women was outside of
their scope of practice.
Pharmacist B added that she would not change anything with their treatment, and would not
recommend weight loss. She also recommended checking blood pressure to make sure it is
within healthy limits.
Pharmacists C, F, I, and L suggested working with the patients to develop diet and exercise
plans for them during pregnancy. Pharmacist C did not recommend a special course of
treatment and said that patient should not be on many medications during pregnancy. She
also said that support groups could help patients adhere to these treatments. Pharmacist F
said that good nutrition could help women have healthier pregnancies. Pharmacist I said that
patients should work with a dietician to gain less weight during pregnancy.
Pharmacist D recommended that pharmacists explained the effects of maternal obesity to the
patients. Pharmacists D and F also recommended counseling patients on healthy weight gain
during pregnancy and emphasizing the health of the baby as a priority.
Pharmacist G said that more research was necessary on how to treat obese pregnant women.
He pointed out that there is not an established protocol for treating these patients.
Pharmacists J and M said that they did not offer advice to obese patients in a retail pharmacy
setting. Both expressed concern about how that could offend patients and hurt the business of
their pharmacies.
Pharmacist H said that obese women were less likely to get and stay pregnant. She also said
that they find out about pregnancy later, which can lead to a lack of prenatal care.
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ii.

Pharmacists C, D, I, J, and L both thought that treating pregnant patients with Type II

diabetes should be centered on blood glucose monitoring. These pharmacists advised patients
to either quit or change their oral antidiabetic medicines to medicines with no potential
teratogenic effects. Pharmacist J encouraged patients to invest in a blood glucose machine,
which periodically tests for blood sugar and can track trends. He also said that yeast
infections can occur more frequently in patients with diabetes. Pharmacist L recommended
planning pregnancies so women can be on the appropriate medications before they get
pregnant.
Pharmacists D, E, and M all stressed the importance patient adherence to treatment regimens
and using diet to control blood sugar. Pharmacist D said that patients should be educated on
why their blood sugar is less stable than usual, and how to control their blood sugar. She also
recommended explaining how Type II diabetes can affect a growing fetus.
Pharmacists I and L recommended women with Type II diabetes to keep a stricter control
over their blood glucose and A1C levels. Pharmacist I also said that since fetal abnormalities
can occur within the first seven weeks, both patients and providers need to be on the same
page about care.
Pharmacist C said that medications were more difficult for pregnant Type II diabetes
patients, and that treatment should emphasize monitoring blood sugar. Pharmacist B and M
said that pregnant patients with Type II diabetes should try not to take multiple medications.
Pharmacist C also recommended talking with Type II diabetic patients in a group setting so
that they could share conversations about issues they face. She said that group education
fosters accountability and encourages women to follow through on what they have learned.
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Pharmacist F said that her diabetes clinic no longer cares for pregnant patients. She added
that Type II patients have the basic knowledge to deal with diabetes, but need to be informed
about how pregnancy can affect diabetes.
Pharmacist G said that he would recommend sugar free drugs to Type II diabetic women.
Pharmacist H said that she would counsel diabetic women on the signs of pregnancy since
diabetes can affect these signs.
Pharmacist A, K said that counseling pregnant women with Type II diabetes was out
of their scope of practice.
iii.
Pharmacist B, C, D, and J said that patients should be informed that gestational
diabetes can recur in subsequent pregnancies.
Pharmacists B, C, D, and L recommended counseling these patients on therapeutic
lifestyle changes since gestational diabetes raises the risk of having Type II diabetes after
pregnancy.
Pharmacists F, I, and J said that patients with gestational diabetes should keep tight
control over their blood glucose levels.
Pharmacists G and M said that pharmacists should make sure that patients with
gestational diabetes know how to treat themselves with insulin since they have never done it
before.
Pharmacist C said that these women should see their providers at least once a year to
have their blood glucose tested
Pharmacist L said that he did not usually see patients with gestational diabetes since
his clinic did not treat pregnant patients.
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Pharmacist E said that patients with gestational diabetes should talk to their
physicians about their treatment and not self-medicate.
Pharmacist A, I, and K said that counseling pregnant women with gestational diabetes
was out of their scope of practice
iv. Pharmacists B, D, F, I said that the cause of the previous preterm birth needed to be
determined before the patient could be treated.
Pharmacist D added that pregnant women who had had a preterm birth should be sure to
attend appointments with their OB/GYN.
Pharmacist H said that pharmacists should emphasize the importance of prenatal care to
women who had had a preterm birth and also discuss possible causes for preterm births.
Pharmacist L recommended referring women who had had a preterm birth to a high risk
OB/GYN.
Pharmacist A, C, E, G, J, K, and M said that counseling pregnant women who had had a
preterm birth was out of their scope of practice
v. Pharmacist B, D, F, I, and L said that the pharmacist must know the reason for the low
weight birth before treating the patient.
Pharmacists J and L observed that smoking can lead to low weight births, and that
pharmacists can counsel patients on how to quit before pregnancy.
Pharmacists H and L said that if the mother had significant nausea during pregnancy, the
child’s size may be affected due to malnutrition.
Pharmacist E said that pregnant patients who had had a low weight birth should be sure to
attend follow-up appointments with their healthcare providers.
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Pharmacist L said that if the parents are small, then the child may be genetically predisposed
to be small.
Pharmacist A, C, G, K, and M said that counseling pregnant women who had had a low
weight birth was out of their scope of practice.
5.

The pharmacists agreed that medications for pregnant women and nursing mothers

must be handled more carefully than medications for the general public. Pharmacist B
recommended that pharmacists check over these prescriptions to make sure of the effects for
the mother and infant. Pharmacists A, E, J, and M all said that pharmacists should explain to
patients what medications are safe for pregnancy and breastfeeding. They also agreed that
medication adherence should be emphasized and that women should not change their
medications without talking to a physician or pharmacist. Pharmacists C, I, and H agreed
with this view and added that community pharmacists should inform patients about which
over the counter medications and supplements are safe to take while pregnant or
breastfeeding. They also suggested reviewing the patient’s medical history to make sure that
all drugs are safe and necessary. Pharmacist H added that if a medication could harm the
mother or child, the pharmacist should inform women of the dangers and talk to the
prescriber about changing the therapy. Pharmacist D echoed this view and said that women
should know how trimesters affect the risk of adverse effects from certain medications.
Pharmacists F and L recommended counseling patients who could become pregnant
on how the medications that they are on could affect potential children. Pharmacist F thought
that pharmacists should ask patients of childbearing age if they were on birth control or plan
on becoming pregnant. She thought that pregnancy should be planned in women with chronic
diseases to optimize outcomes for both mother and child. If the woman plans on getting
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pregnant, her medications should be changed to drugs that are not harmful during pregnancy.
She stressed that diabetes and blood pressure change from trimester to trimester and require
tight control to stay regulated. Pharmacist L stated that diabetic patients should be counseled
on medications during pregnancy and only be on medications that cannot go into breastmilk.
He said that insulin is fine during breastfeeding, but some other antidiabetics can be
transmitted in the breastmilk.
Pharmacist G recommended that community pharmacists check drug interactions for
these patients. He said that electronic prescriptions and databases of certain medications
including Sudafed can help pharmacists monitor the patient’s medication history, especially
if they get medicines at multiple pharmacies.
Pharmacist K was very cautious about medication use in pregnancy and
recommended that patients take as little medication as possible during pregnancy unless there
is clear data on fetal safety.
6.

All but one of the pharmacists I spoke to said that interacting with patients is an

important way for pharmacists to improve prenatal care. Pharmacist A stated that
pharmacists need to make educating the population on prenatal care a priority, since lack of
education can lead to adverse outcomes. Pharmacist D echoed this idea, and encouraged
pharmacists to educate and identify high risk patients on issues they may face in their
pregnancies as well as medication safety. Pharmacist E said that pharmacists should reinforce
the importance of adherence to medication to patients and also advise patients against selfmedicating with herbal medications. Pharmacists F and H both suggested having reading
material available in the pharmacies that listed resources for pregnant women, as well as
counseling patients individually when possible. Pharmacist F acknowledged the difficulty of
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finding time to educate patients in a community pharmacy setting because of limited time for
patient interaction. In a clinical setting, she recommended tailoring patient care to each
patient’s individualized medications and health concerns. She emphasized the importance of
affordability and awareness in providing education in both clinical and community settings.
Pharmacists B and G suggested that pharmacists need to have full access to patient
information and specialized training to best provide prenatal care to patients. Pharmacist B
reiterated the importance of pharmacists having full access to the patient’s profile to provide
the best care. Pharmacist G pointed out that prenatal care education is not mandatory for
pharmacists, which can lead to gaps in knowledge on how to treat these patients.
Several of the pharmacists also discussed the importance of a healthy lifestyle in a
health pregnancy. Pharmacist I thought that pharmacists should make sure that women
understand the importance of prenatal care. She added that women with chronic diseases
needed to have an appropriate diet. Pharmacist J took this idea further by saying that
pharmacists could encourage women in childbearing years to stay healthy by exercising
regularly, having proper nutrition, sleeping well, and giving up alcohol and nicotine. He
recommended that pregnant women as few medicines as they could. Pharmacist B agreed
with this and added that pharmacists should provide extra support for these patients.
Pharmacists L and M both focused on the importance of taking folic acid and prenatal
vitamins during pregnancy. Pharmacist L stated that pharmacists should talk to patients about
family planning and nutrition. Since folic acid is especially important in the first eight weeks
of pregnancy, he recommended that pharmacists stock affordable folic acid so that patients
would be more likely to take it. He also recommended educating patients on how to read
nutrition labels and how to be healthy on a tight budget.
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Pharmacist K was the only pharmacist who did not respond to this question.
7.

Pharmacists B, C, G, H, and J had not heard of population health. Pharmacists D, K

and M knew a little about population health. Pharmacists A, E, F, I, and L had all heard of
population health. Pharmacists A and B discussed how groups could be beneficial for
improving the health of the population. Pharmacist A maintained that treatment still needed
to be one on one, but groups could reinforce individual therapy. Pharmacist B suggested that
pharmacists could hold group classes on important topics for the population like tobacco
cessation, nutrition and supplement awareness. Pharmacists B and M both said that
pharmacists should strive to dispel misinformation in the community. Pharmacist M focused
on how pharmacists should be proactive about interacting with patients and make sure that
patients understand their medications.
Pharmacists C, D, E, and L all said that population health involved looking at health
trends in the population they served to determine the best ways to treat their patients.
Pharmacist L was in favor of treating groups and analyzing their outcomes to produce the
best treatment protocols over time. Pharmacist E recommended putting patients into different
categories based on disease state and treating based on those categories. Pharmacist D used
geographic area to identify health needs in a population. She also discussed how community
health centers are helping patients who would otherwise fall through the cracks, and
referenced grants, programs, and research that are working together to improve population.
Pharmacist C focused on environmental factors for disease and how changing these factors
can lessen the prevalence of disease in a population.
Pharmacists F, G, and I focused on how using community resources effectively can
improve population health. Pharmacist F spoke about how health departments can raise
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awareness of affected populations. She also supported reaching out to medically underserved
communities as a group to improve access for patients. Pharmacist G agreed and added that
there were some church organizations for prenatal care that used principles of population
health. Pharmacist I thought that pharmacists should be well informed about common heath
issues in the population they served and address their services to these issues.
Pharmacist H stressed the importance of the pharmacist’s point of view in providing
care for patients. However, Pharmacist K reiterated how chain community pharmacies have
little time for patient interactions. Pharmacist J did not answer the second part of this
question.
8.

Most of the pharmacists agreed that raising awareness for health issues and improving

communication between pharmacists and members of the community was important for
improving prenatal and postnatal pharmaceutical care.
Pharmacists B, D, G, H, K, and M agreed that educating women in a group setting
can help outcomes by spreading information to many people instead of just one. Pharmacist
B claimed that classes can also serve as a support group, especially when patients are trying
to quit smoking. Pharmacist D urged pharmacists to look into partnering with WIC,
Medicaid, and other organization to provide classes on community health issues. Pharmacists
G and M agreed that educating women could have a snowball effect in the community with
women sharing their knowledge with others in similar situations. Pharmacist K said that
health professionals should look into more venues for providing group educations, as well as
partnering with doctors, nurses and nutritionists to provide prenatal care.
Pharmacists C, E, and F highlighted how pharmacists need to be aware of community
issues to effectively counsel patients. They all agreed that pharmacists should target care for
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pregnant women by focusing on specific health issues they may face as a population. They
also said that pharmacists should be sure to answer patient questions and ask themselves how
their pharmacy could improve community health.
Pharmacists J, and L focused on how pharmacists could use population health
concepts to improve individual care. Pharmacist J thought that prescribers and pharmacists
should be educated on recommendations for care, especially concerning prenatal vitamins.
Pharmacist J also said that knowing the health trends of the population could give
pharmacists insight into how to treat individual patients. He also stressed the importance of
having a full medical profile on patients to provide the best treatment. Pharmacist L focused
on educating individual patients to their level. He discussed the importance of having
wellness and nutrition programs for prenatal care as well as providing education on family
planning. He said not to assume that the patients understand the terms associated with their
disease, and to take care to explain things in easy to understand terms. He recommended
asking patients about their disease states to make sure that they understand their conditions.
He stressed educating patients to their education level. He also discussed how lack of
provider status for pharmacists means that pharmacists are not paid for patient consultation.
This means that pharmacies only make money by filling prescriptions, which is driving down
the time for patient interactions. Pharmacist A did not respond to this question.
9.

Pharmacists B, C, F, G, H, J and M all thought that pharmacists should communicate

more with physicians to get a clear profile of each patient. Clear communication will also
help pharmacists counsel patients on medication adherence. Pharmacists B and C agreed that
working with the physicians to identify needs and find solutions could improve patient care.
Pharmacist G agreed with this and added that pharmacists must be vigilant to make sure that
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all prescriptions are safe and necessary for each patient. Pharmacist M referred to this idea as
the pharmacists being the bridge between physician instructions and patient interpretation.
Some other pharmacists focused on improving patient and pharmacist interactions to
improve prenatal and postnatal care. Pharmacists C, E, and G all said that pharmacists should
emphasize adherence to patient treatment plans to improve prenatal and postnatal healthcare.
Pharmacists A, C, F, and K all focused on patient education. Pharmacists A and K said that
pharmacists should review prescription medications, herbal supplements, and over the
counter medications for pre and post-natal care.
Pharmacists B, G, and L said that listening to patients and paying attention to their
needs was the best way to provide prenatal and postnatal care. Pharmacist B recommended
asking patients about their struggles and then looking into options to help each patient.
Pharmacist L also advocated asking women how they felt post-partum and also watching for
signs of post-partum depression.
Pharmacists I and J agreed that patients should have a patient centered medical home
that consists of a team of healthcare professionals working together to provide care.
Pharmacist I said that pharmacists should inform other healthcare providers about the
services they can provide to patients. Pharmacist J said that pharmacists in the same office as
other healthcare providers could give advice on nutrition and exercise to patients. She said
that since pharmacists were not recognized as healthcare providers, it was difficult to get
reimbursements for patient counseling, which could discourage counseling.
10.

Pharmacists C, F, G, and H agreed that the best place for a women to receive prenatal

care was somewhere accessible where she feels comfortable. Pharmacist C reflected that
prenatal care can be difficult if providers are far away from patients. Pharmacist F said that

59

the best setting depends on what the patient has access to, and where the patient trusts the
providers. Pharmacist G proposed that some women may benefit from home visits. He also
thought that places providing prenatal care should have a more comfortable atmosphere to
put patients at ease. Pharmacist H agreed and said that patients usually see pharmacists first
to fill their prescriptions.
Pharmacists B, D, and E all agreed that prenatal care was best provided at a doctor’s
office. Pharmacist B added that community pharmacists were well equipped to answer
questions about postnatal care. Pharmacist D said that some community health centers offer
programs for high risk pregnancies and can offer referrals for patients. She recommended
developing a protocol for treating these patients.
Pharmacists A and M agreed that if pharmaceutical care should be given in a clinical
pharmacy setting. Since chain retail pharmacies are not designed for counseling, lack of
privacy can be an issue.
Pharmacist I thought that any setting was good for providing prenatal care, as long as
everyone was communicating with each other. If the patient has chronic conditions, then a
high risk OB/GYN should be part of the healthcare team.
Pharmacist L thought that some prenatal care could be given in a group setting, since a group
may provide reinforcement for care. He also supported healthcare teams to treat pregnant
women with chronic diseases. He proposed a team made of a high risk OB/GYN, pharmacist,
nutritionist, and nurse educator to best treat these patients.
Pharmacist J thought that prenatal care should be given by the provider with the patient’s full
medical history.
Pharmacist K maintained that one on one interventions were best for providing prenatal care.
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11.

Pharmacists A, E, F, G, H, I, L, and M agreed that lack of patient education was a

major gap in prenatal and post-natal care. These pharmacists agreed that pharmacists should
be proactive in educating women on their medications and potential side effects. Pharmacist
E and G said that many women lack a reliable source of information about medication safety
during pregnancy and that pharmacists should step up to inform patients about this.
Pharmacists F and L suggested that women schedule a follow-up appointment with the
pharmacy to go over medications and side effects. Pharmacist H said that pharmacists need
to advertise their services to the population more effectively to improve patient outcomes.
Pharmacist M suggested that pharmacists have a list of medicines that are safe during
pregnancy to give to women who are unsure.
Pharmacists B, C, D, and J did not see a clear role for pharmacists in providing prenatal or
post-natal care. Pharmacist B thought that women differed in their willingness to seek out
prenatal care. Pharmacist D echoed this idea by saying that many women got lost in the
system since providers see so many patients. Pharmacist C thought that pharmacists were
better suited to provide preventative care like immunizations instead of being directly
involved with prenatal care. Pharmacist J said that pharmacists and providers did not usually
monitor postnatal patients. She thought that pharmacists could get more involved in postnatal
care by training a pharmacist to care for women with gestational diabetes.
Pharmacists G, J, and K observed that post-partum depression was often overlooked
when providing postnatal care. They recommended monitoring women on antidepressants to
make sure that the medicines were not being transmitted through breastmilk. They also said
that women on antidepressants should be monitored for hypertension. Pharmacists G and K
said that hormone levels should be monitored in women to look for signs of post-partum
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depression. Pharmacist K thought that hormone therapy could possibly ease post-partum
depression with fewer side effects than traditional antidepressants.
Pharmacist L thought that food deserts and lack of access to nutritious food was a
major health concern.
12.

Pharmacists A, B, C, D, E, F, H, I, K, L, and M all recommended open lines of

communication between pharmacists and non-pharmacists to improve working relations.
Pharmacists A and I encouraged pharmacists to let other professionals know about their role
in care with over the counter drugs and herbal products. Pharmacist A also stressed the
importance of the pharmacists working with lactation consultants to make sure that
breastfeeding is safe for mothers. Pharmacist B supported team based healthcare and
recommended that pharmacists have an open conversation with their teammates about each
member’s strengths and scopes of practice. She said that it was important for teammates to
collaborate and not compete in healthcare. Pharmacists C, D, E, H, L, and M all advocated
for teammates to get to know pharmacists so that they can better work together. They
highlighted that pharmacists offer services like immunizations and medication therapy
management which can benefit patients. Pharmacist M added that pharmacists should be
more proactive in educating patients on their medications.
Pharmacists G, I, and J all thought that pharmacists should lobby for more continuing
education offered on maternal pharmaceutical care.
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